Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06065488
Other study ID # P.T.REC/012/004688
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 6, 2023
Est. completion date February 14, 2024

Study information

Verified date February 2024
Source MTI University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate the effects of Functional ankle taping correction on plantar foot ulcer healing in diabetic patients. This study will be carried out at the outpatient clinic of the faculty of physical therapy, modern university for technology and information, Om El masryeen general Hospital and El Rahma - private clinic. All participants will sign a written consent form after receiving full information about the purpose of the study, procedure, possible benefits, privacy, and use of data.


Description:

Design of the study: Randomized controlled trial. Subject's selection: Estimated sample size is 70 subjects the actual sample size will be calculated after pilot study. They will be assigned into two equal groups: 1. Group A (Ankle KT group): This group includes 35 patients with chronic unhealed plantar foot ulcers for longer than three months; they will receive functional ankle taping, medical treatment, and dressing according their cases. The tape was applied for 5 days and then removed for 1 day to allow skin perspiration. This process was repeated for successive 8 weeks. The patient was instructed to avoid vigorous activities for 30 min, which is required for the glue to become fully activated (Andrýsková et al., 2020) 2. Group B (Control group Ankle shame KT ): This group includes 35 patients with chronic unhealed plantar foot ulcers for longer than three months. Shame taping group, a placebo taping method considered to be ineffective ( not from insertion to origin of muscles) with the same material without tension , they will receive medical treatment, and dressing according their cases The shame tape was applied for 5 days and then removed for 1 day to allow skin perspiration. This process was repeated for successive 8 weeks. The patient was instructed to avoid vigorous activities for 30 min, which is required for the glue to become fully activated. (Andrýsková et al., 2020) Patients were followed for 8 weeks or until ulcer healing, whichever came first. The protocol was designed according to the fundamental treatment principal of the expert panel to the 2022 American Diabetic Association consensus development conference on diabetic foot wound care.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date February 14, 2024
Est. primary completion date January 26, 2024
Accepts healthy volunteers No
Gender All
Age group 42 Years to 60 Years
Eligibility 1. Inclusion Criteria: The subject selection will be according to the following criteria: - Undergoing treatment for a Wagner grade II or III diabetic foot ulcer - Age between 42 and 60 years. - No systemic diseases such as musculoskeletal disorders, heart diseases, or neurological diseases that can hinder ability to participate in the study - Not receiving other treatments that could affect wound healing (negative-pressure wound treatment, hyperbaric oxygen treatment, a special wound care product, special wound dressing, or growth factor. - Not using another complementary treatment method (herbal wound care products and Participating subjects were required to be able to walk 10 m unassisted. - Absence of protective sensation on the plantar foot as determined using a 10-gram monofilament following criteria from the International Working Group on the Diabetic Foot 2023 - All the patients have active unilateral plantar DFU at least 1cm2 (greatest length x greatest width) and not healed > 3months duration. Never received the same intervention from other researchers and health Professionals.. • Ability to walk independently for 30 steps or 10 min. 2. Exclusion Criteria: The potential participants will be excluded if they meet one of the following criteria: - Patients with inadequate vascular circulation (ankle-brachial pressure index <0.8 or toe systolic blood pressure <40 mmHg) - Patient with skin allergy with generalized osteoporosis, or who had fractures of any bones in the lower extremity. - Previous ankle pathology or surgery to the lower limb within the last 12 months, current illness or infection, neurological deficits affecting the lower limb and skin conditions or edema affecting the lower limb ,Severe uncontrolled hypertension. - Pregnant women. - Un controlled diabetes - Pedal amputations and arthritis. - Ulcer developed secondary to acute trauma; ulcer developed secondary to burns. - Foot deformities included hallux valgus, hallux rigidus, pes planus, pes cavus, low forefoot arch, and hammer toes, Skin callosities, heel fissures, a hypotrophic fat pad, and nail deformities

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ankle kinesio tap
Kinesio Tape is popular among athletes and non-athletes for its ability to protect, support, and promote activity in overworked muscles. Few people are aware, however, that its healing benefits don't end there. Research studies show that taping ankle with Kinesio Tape actually improves ankle range of motion.

Locations

Country Name City State
Egypt Ahmed Mohamed Ahmed Abdelhady Cairo

Sponsors (1)

Lead Sponsor Collaborator
MTI University

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Bus SA, van Deursen RW, Armstrong DG, Lewis JE, Caravaggi CF, Cavanagh PR; International Working Group on the Diabetic Foot. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:99-118. doi: 10.1002/dmrr.2702. — View Citation

Lazzarini PA, Jarl G, Gooday C, Viswanathan V, Caravaggi CF, Armstrong DG, Bus SA. Effectiveness of offloading interventions to heal foot ulcers in persons with diabetes: a systematic review. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1(Suppl 1):e3275. doi: 10.1002/dmrr.3275. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Maximum plantar peak pressures of ulcerated foot Maximum plantar peak pressures were measured using Tekscan® pressure mat system (Boston , MA). - Patients were given time to familiarise themselves with the protocol. - Prior to testing he mat was calibrated for each individual's mass using mat-Scan® System Research software (Tekscan, Boston, MA). - Once calibration was completed Patient was asked to walk across the plantar pressure mat which placed in the center of walkway - The method has been previously validated and involves each participant taking two steps before landing on the pressure mat. - Trials were excluded and repeated if a participant appeared to target the platform and alter their gait pattern to ensure full contact with the mat - - Collecting data from mat-based Stride way System, a 150 cm long and 60 cm Wide to generate maximum Peake pressure by quantifying the pressure exerted on the force sensors\ - Direct cont Baseline then after 8 weeks
Secondary Ankle dorsiflexion range of motion of ulcerated foot The maximum dorsiflexion angle at the ankle joint was measured with hand - held standard goniometer in a standing position with the knee extended, with the heel in contact with the ground. Participants were asked to lean forward, directing their knees toward the wall. While the participant maintained his or her maximal dorsiflexion position, a standard goniometer was aligned with floor (stable arm) and through the shaft of the fibula (mobile arm) by visually bisecting the lateral malleolus and the fibular head. Participants were allowed three practice trials. Baseline then after 8 weeks
Secondary Wound surface area by +Wound Desk mobile application To start working with the application, it is required to sign in into the account. A patient's profile is completed; where it is required to indicate the location and how the trauma happened (one of several options is offered). Based on the completed profile of the dynamic monitoring process, one of standard treatment options is offered. To obtain photos, Take anew photo mode is selected in the application, which turns on the mobile application photo camera. +WD indicator should be placed next to the studied wound. The wound area is photographed, and the program recognizes +WD marker thereafter and requires a manual detection of wound borders using a thumb knob. Next, an automatic calculation of the wound surface area is performed and the result is provided Baseline then after 8 weeks
Secondary Wound volume assessment - Using sterilized siring and saline solution. - Filing the sterilized siring of 5 cm3 with saline solution. - Then filing the wound by the kwon volume of the saline solution - It is an easy accurate method for wound volume estimation Baseline then after 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03942081 - Diabetic Foot Ulcer Imaging- Study 2 N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Recruiting NCT02239419 - Evaluation of Carbothera in the Treatment of Foot Ulcers N/A
Completed NCT02131961 - EZCast-DFU Study With Portal for Application of Topical Medications Phase 1
Recruiting NCT05556954 - Diabetic Foot Ulcers Microbiome and Pathogen Identification
Recruiting NCT04210089 - Total Contact Soft Cast in Diabetic Foot Ulcers N/A
Not yet recruiting NCT05415878 - Impact of Removable Cast Walker Design on Usability for Patients With Diabetic Foot Ulcers N/A
Completed NCT02852148 - ACTICOAT™ for the Treatment of Burns and Chronic Wounds N/A
Completed NCT01551667 - Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds N/A
Recruiting NCT05610865 - Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers Phase 1
Recruiting NCT05930210 - A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer Phase 3
Completed NCT02732886 - Betafoam Diabetes Mellitus Foot Study N/A
Completed NCT03853941 - Adherence to Activity Limitations in Diabetes N/A
Completed NCT02512159 - Skin Ulcers Treatment With an Handicraft Topical Device Phase 4
Completed NCT01235260 - Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes N/A
Completed NCT02672436 - ENERGI-F703 for Diabetic Foot Ulcers Phase II Study Phase 2
Recruiting NCT05189470 - Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers N/A
Not yet recruiting NCT06262854 - Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study N/A
Recruiting NCT06035536 - Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers N/A
Completed NCT04244201 - Vaporous Hyperoxia Therapy (VHT) in the Treatment of Foot Wounds N/A